Profiling with senescence-associated secretory phenotype score identifies GDC-0879 as a small molecule sensitizing glioblastoma to anti-PD1
Abstract Senescence-associated secretory phenotype (SASP) in cancer refers to the bioactive secretome produced by senescence cells in the tumor microenvironment, which could be triggered by therapeutics or local stress conditions. Here, we provided a SASP Score in glioblastoma (GBM) with generating...
Saved in:
| Main Authors: | Yang Liu, Yuan Feng, Lin Cheng, Yangxi Xu, Anhua Wu, Peng Cheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-08-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07915-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GDC: Integration of Multi‐Omic and Phenotypic Resources to Unravel the Genetic Pathogenesis of Hearing Loss
by: Hui Cheng, et al.
Published: (2025-08-01) -
NFATc1 facilitates hepatocellular carcinoma progression by regulating the senescence-associated secretory phenotype
by: Zhaobin Chen, et al.
Published: (2025-07-01) -
Senescence-associated secretory phenotype in lung cancer: remodeling the tumor microenvironment for metastasis and immune suppression
by: Chen Chen, et al.
Published: (2025-05-01) -
TIGAR coordinates senescence-associated secretory phenotype via lysosome repositioning and α-tubulin deacetylation
by: Hae Yun Nam, et al.
Published: (2024-12-01) -
Senescence-associated secretory phenotype regulation by dual drug delivery biomimetic nanoplatform for enhanced tumor chemotherapy
by: Anni Wang, et al.
Published: (2024-09-01)